跳至主要内容
临床试验/NCT05226286
NCT05226286已完成不适用

Evaluation of Implantable Tibial Neuromodulation Pivotal Study

MedtronicNeuro58 个研究点 分布在 1 个国家目标入组 188 人开始时间: 2022年1月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
188
试验地点
58
主要终点
UUI Responder

研究概览

简要总结

The purpose of this prospective, multicenter study is to assess the safety and efficacy of tibial neuromodulation using the Medtronic Tibial Neuromodulation (TNM) system.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects 18 years of age or older
  • Qualifying voiding diary
  • Have a diagnosis of UUI for at least 6 months
  • Failed and/or are not a candidate for conservative therapies.
  • Willing and able to accurately complete study diaries, questionnaires, attend visits, operate the system, and comply with the study protocol
  • Willing and able to provide signed and dated informed consent

排除标准

  • Have primary stress incontinence
  • History of a prior implantable tibial neuromodulation system
  • Anatomical defects, clinically significant edema or previous surgeries which precludes use of the device
  • Previous pelvic floor surgery in the last 6 months
  • Women who are pregnant or planning to become pregnant during the course of the study
  • Characteristics indicating a poor understanding of the study or characteristics that indicate the subject may have poor compliance with the study protocol requirements.
  • Concurrent participation in another clinical study that may add additional safety risks and/or confound study results.

结局指标

主要结局

UUI Responder

时间窗: 6 months

Proportion of TNM subjects experiencing a reduction of 50% or more in daily urinary urge incontinence (UUI) episodes (UUI responder rate) at 6 months after device implant.

次要结局

  • UUI Change From Baseline(6 months)
  • UF Change From Baseline(6 months)
  • UPS Change at 6 Months(6 months)
  • OAB-q Change From Baseline(6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (58)

Loading locations...

相似试验

相关资讯